tiprankstipranks
United Therapeutics (MX:UTHR)
:UTHR
Mexico Market
UTHR
United Therapeutics
RESEARCH TOOLSreports

United Therapeutics (UTHR) Ratios

0 Followers

United Therapeutics Ratios

MX:UTHR's free cash flow for Q2 2026 was $0.87. For the 2026 fiscal year, MX:UTHR's free cash flow was decreased by $ and operating cash flow was $0.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.73 6.60 5.25 4.41 9.85
Quick Ratio
 5.41 6.28 5.03 4.28 9.55
Cash Ratio
 2.97 2.78 2.30 1.50 2.80
Solvency Ratio
 1.68 1.81 1.38 0.88 0.62
Operating Cash Flow Ratio
 2.77 2.78 1.80 1.22 2.34
Short-Term Operating Cash Flow Coverage
 0.00 0.00 4.42 2.44 0.00
Net Current Asset Value
$ 2.66B$ 2.92B$ 2.95B$ 2.37B$ 2.13B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 0.04 0.10 0.13
Debt-to-Equity Ratio
 0.00 <0.01 0.05 0.12 0.17
Debt-to-Capital Ratio
 0.00 <0.01 0.04 0.10 0.14
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.05 0.14
Financial Leverage Ratio
 1.13 1.11 1.14 1.20 1.26
Debt Service Coverage Ratio
 115.85 73.84 3.82 2.39 25.22
Interest Coverage Ratio
 116.95 77.81 32.10 19.98 30.24
Debt to Market Cap
 0.00 0.00 0.02 0.07 0.06
Interest Debt Per Share
 0.28 1.29 7.59 16.22 18.29
Net Debt to EBITDA
 -1.09 -0.84 -0.84 -0.37 -0.15
Profitability Margins
Gross Profit Margin
86.14%87.92%89.24%88.94%92.42%
EBIT Margin
50.25%54.46%54.98%57.30%51.08%
EBITDA Margin
52.38%57.15%57.50%59.58%53.73%
Operating Profit Margin
44.49%47.67%47.86%50.91%50.60%
Pretax Profit Margin
49.87%53.85%53.49%54.75%49.09%
Net Profit Margin
41.56%41.94%41.53%42.31%37.56%
Continuous Operations Profit Margin
41.56%41.94%41.53%42.31%37.56%
Net Income Per EBT
83.34%77.88%77.65%77.28%76.51%
EBT Per EBIT
112.08%112.96%111.76%107.54%97.03%
Return on Assets (ROA)
18.16%16.94%16.23%13.74%12.03%
Return on Equity (ROE)
20.18%18.81%18.55%16.46%15.16%
Return on Capital Employed (ROCE)
21.22%20.73%20.78%18.62%17.18%
Return on Invested Capital (ROIC)
17.69%16.13%15.44%13.54%13.15%
Return on Tangible Assets
18.45%17.19%16.48%13.96%12.12%
Earnings Yield
6.31%6.18%7.49%9.57%5.75%
Efficiency Ratios
Receivables Turnover
 10.17 9.09 10.30 8.35 8.79
Payables Turnover
 0.88 54.14 51.62 45.98 35.78
Inventory Turnover
 2.26 2.10 1.96 2.30 1.44
Fixed Asset Turnover
 1.63 1.84 2.35 2.23 2.25
Asset Turnover
 0.44 0.40 0.39 0.32 0.32
Working Capital Turnover Ratio
 1.23 1.01 0.98 0.80 0.77
Cash Conversion Cycle
 -217.89 207.28 214.45 194.27 285.13
Days of Sales Outstanding
 35.90 40.16 35.43 43.74 41.55
Days of Inventory Outstanding
 161.80 173.86 186.09 158.47 253.78
Days of Payables Outstanding
 415.59 6.74 7.07 7.94 10.20
Operating Cycle
 197.70 214.02 221.52 202.21 295.33
Cash Flow Ratios
Operating Cash Flow Per Share
 39.56 35.24 29.36 20.90 17.64
Free Cash Flow Per Share
 25.66 23.49 23.91 15.97 14.59
CapEx Per Share
 13.90 11.75 5.45 4.92 3.05
Free Cash Flow to Operating Cash Flow
 0.65 0.67 0.81 0.76 0.83
Dividend Paid and CapEx Coverage Ratio
 2.85 3.00 5.38 4.24 5.78
Capital Expenditure Coverage Ratio
 2.85 3.00 5.38 4.24 5.78
Operating Cash Flow Coverage Ratio
 0.00 41.52 4.42 1.40 1.00
Operating Cash Flow to Sales Ratio
 0.53 0.49 0.46 0.42 0.41
Free Cash Flow Yield
5.28%4.82%6.78%7.26%5.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 16.13 16.17 13.34 10.45 17.40
Price-to-Sales (P/S) Ratio
 6.56 6.78 5.54 4.42 6.53
Price-to-Book (P/B) Ratio
 3.25 3.04 2.47 1.72 2.64
Price-to-Free Cash Flow (P/FCF) Ratio
 18.94 20.74 14.76 13.77 19.06
Price-to-Operating Cash Flow Ratio
 12.33 13.83 12.02 10.52 15.77
Price-to-Earnings Growth (PEG) Ratio
 1.77 1.16 0.52 0.33 0.34
Price-to-Fair Value
 3.25 3.04 2.47 1.72 2.64
Enterprise Value Multiple
 11.44 11.03 8.80 7.05 12.01
Enterprise Value
 18.89B 20.07B 14.55B 9.78B 12.49B
EV to EBITDA
 11.44 11.03 8.80 7.05 12.01
EV to Sales
 5.99 6.30 5.06 4.20 6.45
EV to Free Cash Flow
 17.29 19.28 13.47 13.09 18.82
EV to Operating Cash Flow
 11.21 12.85 10.96 10.00 15.57
Tangible Book Value Per Share
 147.56 157.56 140.09 125.44 104.44
Shareholders’ Equity Per Share
 150.24 160.19 142.57 127.88 105.42
Tax and Other Ratios
Effective Tax Rate
 0.17 0.22 0.22 0.23 0.23
Revenue Per Share
 74.05 71.84 63.66 49.73 42.56
Net Income Per Share
 30.77 30.13 26.44 21.04 15.98
Tax Burden
 0.83 0.78 0.78 0.77 0.77
Interest Burden
 0.99 0.99 0.97 0.96 0.96
Research & Development to Revenue
 0.17 0.17 0.17 0.18 0.17
SG&A to Revenue
 0.23 0.23 0.22 0.17 0.21
Stock-Based Compensation to Revenue
 0.05 0.05 0.05 0.02 0.06
Income Quality
 1.29 1.17 1.11 0.99 1.10
Currency in USD